2425 55th Street Suite 100
Boulder, CO 80301
Phone: (303) 243-5190
Fax: (303) 243-5193
OPX Biotechnologies, Inc. is a Colorado-based bioproducts company using proprietary bioengineering technology to convert renewable feedstocks into biofuels and green chemistry products. The OPX EDGE – Efficiency Directed Genome Engineering – technology platform enables rapid, rational, and robust optimization of microbes and bioprocesses. Compared to petroleum-based alternatives, OPX EDGE bioprocesses deliver equivalent product performance with improved sustainability at lower cost. Using the EDGE platform, OPX has produced multiple biofuel and green chemistry products at laboratory scale from several different renewable feedstocks. OPX is proving its economical bioprocesses at larger scale in advance of a demonstration plant startup in 2011. OPX is located in Boulder, Colorado and is funded by Altira Group LLC, Braemar Energy Ventures, MDV – Mohr Davidow Ventures and X/Seed Capital
The OPX EDGE™ – Efficiency Directed Genome Engineering – technology platform enables rapid, rational, and robust optimization of microbes and bioprocesses to manufacture bioproducts with equivalent performance and improved sustainability at lower cost compared to petroleum-based alternatives. Using OPX EDGE, they identify the genes that control microbial metabolism and then implement a comprehensive, rational genetic change strategy to simultaneously optimize microbial production pathways and vitality as well as overall bioprocess productivity. OPX EDGE includes a first-of-its-kind, massively parallel, full genome search technology known as SCALEs. The OPX EDGE technology is 1000 to 5000 times faster than conventional genetic engineering methods, meaning OPX creates optimized microbes and bioprocesses within months rather than years. The bottom line – OPX EDGE makes possible biofuels and green chemistry products that have up to 50% lower cost than petroleum-based alternatives.